A Director at KalVista Pharmaceuticals Inc (NASDAQ: KALV) is Buying Shares
Today, a Director at KalVista Pharmaceuticals Inc (KALV – Research Report), Albert Cha, bought shares of KALV for $1.09M. Following this transaction Albert Cha’s holding in the company was increased by 14.46% More »
Credit Suisse Sticks to Their Buy Rating for International Business Machines Corporation (IBM)
Credit Suisse analyst Matthew Cabral maintained a Buy rating on International Business Machines Corporation (IBM – Research Report) today and set a price target of $173. The company’s shares opened today at More »
